title: Propranolol to treat infantile hemangioma (IH) in patients with congenital heart disease.
authors.affiliation: Department of Dermatology, School of Medicine, Pusan National University, Yangsan, Korea.
authors.forename: Hyang-Suk
authors.initials: HS
authors.lastname: You
authors.affiliation: Department of Dermatology, School of Medicine, Pusan National University, Yangsan, Korea.
authors.forename: Hoon-Soo
authors.initials: HS
authors.lastname: Kim
authors.affiliation: Department of Dermatology, School of Medicine, Pusan National University, Yangsan, Korea; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
authors.forename: Byung-Soo
authors.initials: BS
authors.lastname: Kim
authors.affiliation: Department of Dermatology, School of Medicine, Pusan National University, Yangsan, Korea; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
authors.forename: Moon-Bum
authors.initials: MB
authors.lastname: Kim
authors.affiliation: Department of Dermatology, School of Medicine, Pusan National University, Yangsan, Korea; Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Busan, Korea. Electronic address: hcko@pusan.ac.kr.
authors.forename: Hyun-Chang
authors.initials: HC
authors.lastname: Ko
mesh_terms: D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D011433:Propranolol / Q000627:therapeutic use*; D011446:Prospective Studies
chemical_list: D011433:Propranolol